AMH and polycystic ovary syndrome: REM analysis of 8 sets of data (n = 869) showed that CC pretreatment (1 ~ 3 cycles) can cause a significant decrease in serum AMH levels in PCOS patients (WMD: -0.89, 95%CI: -1.55 to -0.23; P = 0.008).